

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.89983771 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.27627669 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.26834762 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.17322110 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.15531036 |
| 6 | vocalization behavior (GO:0071625) | 5.15125714 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 5.00203757 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.98254936 |
| 9 | neurotransmitter secretion (GO:0007269) | 4.82197406 |
| 10 | glutamate secretion (GO:0014047) | 4.75446006 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.58327865 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.56788984 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.52630149 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.51731870 |
| 15 | regulation of synaptic vesicle transport (GO:1902803) | 4.40578838 |
| 16 | gamma-aminobutyric acid transport (GO:0015812) | 4.38308723 |
| 17 | protein localization to synapse (GO:0035418) | 4.33620722 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.32401502 |
| 19 | neuromuscular process controlling posture (GO:0050884) | 4.29077100 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.27668958 |
| 21 | neurotransmitter transport (GO:0006836) | 4.18342317 |
| 22 | exploration behavior (GO:0035640) | 4.14997086 |
| 23 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.03459352 |
| 24 | positive regulation of synapse maturation (GO:0090129) | 3.91312146 |
| 25 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.88741953 |
| 26 | proline transport (GO:0015824) | 3.85934305 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 3.84952715 |
| 28 | regulation of neurotransmitter levels (GO:0001505) | 3.81765338 |
| 29 | cellular potassium ion homeostasis (GO:0030007) | 3.78273407 |
| 30 | transmission of nerve impulse (GO:0019226) | 3.77589745 |
| 31 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.76559967 |
| 32 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.76113048 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 3.75384631 |
| 34 | neuron recognition (GO:0008038) | 3.73584812 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 3.71935036 |
| 36 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.71805848 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 3.69177651 |
| 38 | activation of protein kinase A activity (GO:0034199) | 3.67202561 |
| 39 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.66356491 |
| 40 | establishment of mitochondrion localization (GO:0051654) | 3.64525646 |
| 41 | positive regulation of neurotransmitter transport (GO:0051590) | 3.63988536 |
| 42 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.61964127 |
| 43 | positive regulation of dendritic spine development (GO:0060999) | 3.60223919 |
| 44 | long-term memory (GO:0007616) | 3.56343409 |
| 45 | mating behavior (GO:0007617) | 3.50254924 |
| 46 | L-amino acid import (GO:0043092) | 3.50135926 |
| 47 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.49632921 |
| 48 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.46036638 |
| 49 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.43720582 |
| 50 | auditory behavior (GO:0031223) | 3.43243685 |
| 51 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.38267415 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.36372832 |
| 53 | amino acid import (GO:0043090) | 3.34992808 |
| 54 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.34181356 |
| 55 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.33638917 |
| 56 | sodium ion export (GO:0071436) | 3.32100016 |
| 57 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.30329716 |
| 58 | synaptic vesicle endocytosis (GO:0048488) | 3.29546307 |
| 59 | dendritic spine morphogenesis (GO:0060997) | 3.28610301 |
| 60 | regulation of vesicle fusion (GO:0031338) | 3.28461181 |
| 61 | axonal fasciculation (GO:0007413) | 3.27853913 |
| 62 | response to histamine (GO:0034776) | 3.26978744 |
| 63 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.26140609 |
| 64 | positive regulation of synapse assembly (GO:0051965) | 3.23778259 |
| 65 | regulation of glutamate secretion (GO:0014048) | 3.23605272 |
| 66 | regulation of synapse structural plasticity (GO:0051823) | 3.22950271 |
| 67 | potassium ion import (GO:0010107) | 3.22659751 |
| 68 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.21032962 |
| 69 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.20062396 |
| 70 | regulation of neurotransmitter secretion (GO:0046928) | 3.19387799 |
| 71 | detection of calcium ion (GO:0005513) | 3.19187150 |
| 72 | neuromuscular synaptic transmission (GO:0007274) | 3.18702956 |
| 73 | regulation of protein kinase A signaling (GO:0010738) | 3.18652400 |
| 74 | postsynaptic membrane organization (GO:0001941) | 3.18282384 |
| 75 | presynaptic membrane assembly (GO:0097105) | 3.16416495 |
| 76 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.16047668 |
| 77 | establishment of synaptic vesicle localization (GO:0097480) | 3.15777417 |
| 78 | synaptic vesicle transport (GO:0048489) | 3.15777417 |
| 79 | positive regulation of membrane potential (GO:0045838) | 3.15030438 |
| 80 | regulation of postsynaptic membrane potential (GO:0060078) | 3.14780152 |
| 81 | regulation of dendritic spine development (GO:0060998) | 3.14674289 |
| 82 | cell migration in hindbrain (GO:0021535) | 3.14573883 |
| 83 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.14214711 |
| 84 | long-term synaptic potentiation (GO:0060291) | 3.12888467 |
| 85 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.12198118 |
| 86 | membrane hyperpolarization (GO:0060081) | 3.12169704 |
| 87 | regulation of synapse maturation (GO:0090128) | 3.11990153 |
| 88 | vesicle transport along microtubule (GO:0047496) | 3.10710204 |
| 89 | startle response (GO:0001964) | 3.10614764 |
| 90 | nucleobase catabolic process (GO:0046113) | 3.09701101 |
| 91 | glycine transport (GO:0015816) | 3.08741146 |
| 92 | synapse assembly (GO:0007416) | 3.06198591 |
| 93 | presynaptic membrane organization (GO:0097090) | 3.06123273 |
| 94 | adult walking behavior (GO:0007628) | 3.05510346 |
| 95 | membrane depolarization during action potential (GO:0086010) | 3.05225102 |
| 96 | neurotransmitter catabolic process (GO:0042135) | 3.03830829 |
| 97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.03726723 |
| 98 | social behavior (GO:0035176) | 3.03364661 |
| 99 | intraspecies interaction between organisms (GO:0051703) | 3.03364661 |
| 100 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.02972892 |
| 101 | regulation of neurotransmitter transport (GO:0051588) | 3.02004484 |
| 102 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.01954889 |
| 103 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.01798416 |
| 104 | cellular sodium ion homeostasis (GO:0006883) | 3.01525905 |
| 105 | synaptic transmission (GO:0007268) | 2.99322564 |
| 106 | behavioral response to cocaine (GO:0048148) | 2.99210070 |
| 107 | neuronal ion channel clustering (GO:0045161) | 2.99088158 |
| 108 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.98896855 |
| 109 | mitochondrion transport along microtubule (GO:0047497) | 2.98896855 |
| 110 | behavioral defense response (GO:0002209) | 2.98892949 |
| 111 | negative regulation of amino acid transport (GO:0051956) | 2.97421671 |
| 112 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.96902151 |
| 113 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.96338190 |
| 114 | response to auditory stimulus (GO:0010996) | 2.95211357 |
| 115 | neurotransmitter uptake (GO:0001504) | 2.94522263 |
| 116 | regulation of synaptic plasticity (GO:0048167) | 2.94060742 |
| 117 | potassium ion homeostasis (GO:0055075) | 2.93559499 |
| 118 | membrane depolarization (GO:0051899) | 2.92111242 |
| 119 | response to pheromone (GO:0019236) | 2.90678184 |
| 120 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.90187704 |
| 121 | prepulse inhibition (GO:0060134) | 2.89845436 |
| 122 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.89284876 |
| 123 | neuromuscular process controlling balance (GO:0050885) | 2.86434892 |
| 124 | cerebellar granule cell differentiation (GO:0021707) | 2.86005513 |
| 125 | regulation of synaptic transmission (GO:0050804) | 2.85310339 |
| 126 | positive regulation of synaptic transmission (GO:0050806) | 2.84464546 |
| 127 | calcium ion-dependent exocytosis (GO:0017156) | 2.83088285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.17048883 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.45739154 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.14151099 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08583841 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02088122 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.80619359 |
| 7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60898846 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.59786439 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.59786439 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.59201520 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54278744 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.54090720 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53736004 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51479862 |
| 15 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.51185687 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47881978 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.40601770 |
| 18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.34629105 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.32227621 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.29478066 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.22767469 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.21414975 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19330331 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.18609583 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16977868 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.06122251 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03847038 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03249154 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.01226941 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.85707124 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.84688159 |
| 32 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.73602650 |
| 33 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.68850731 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.67034191 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65284740 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62993899 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.57286399 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54127276 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.53798600 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51381176 |
| 41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43089945 |
| 42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42650060 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.42270498 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41517102 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35895464 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35731983 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35237324 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34445551 |
| 49 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.34354669 |
| 50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.34021360 |
| 51 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33188029 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.32470145 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31237627 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31035643 |
| 55 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30558029 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30275871 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.26768530 |
| 58 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26150714 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24394744 |
| 60 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23958816 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23514624 |
| 62 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19682581 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18530048 |
| 64 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.17905877 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17078458 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13311339 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11768336 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11363449 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11122432 |
| 70 | VDR_22108803_ChIP-Seq_LS180_Human | 1.11027735 |
| 71 | AR_19668381_ChIP-Seq_PC3_Human | 1.10235703 |
| 72 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10061133 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09539156 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09248266 |
| 75 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07303793 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06739122 |
| 77 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05853649 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05060353 |
| 79 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03844366 |
| 80 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.03364429 |
| 81 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.01652185 |
| 82 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.99560039 |
| 83 | JUN_21703547_ChIP-Seq_K562_Human | 0.97604693 |
| 84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97321449 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97321449 |
| 86 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96850697 |
| 87 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96516249 |
| 88 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96360176 |
| 89 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95870619 |
| 90 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95476770 |
| 91 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95439935 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95326093 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94996507 |
| 94 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.92757768 |
| 95 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92387272 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91631724 |
| 97 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90248445 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90166048 |
| 99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89712245 |
| 100 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.87114879 |
| 101 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86660937 |
| 102 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.86172338 |
| 103 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.85969356 |
| 104 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.85340212 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85257970 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83281710 |
| 107 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.83172567 |
| 108 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.82843675 |
| 109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82625011 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82471131 |
| 111 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.81544770 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80509461 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80050824 |
| 114 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.79407719 |
| 115 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79274142 |
| 116 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.78971969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.97024913 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.93253711 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.80791802 |
| 4 | MP0009046_muscle_twitch | 3.50125627 |
| 5 | MP0009745_abnormal_behavioral_response | 3.32949417 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.31405483 |
| 7 | MP0002064_seizures | 3.26114243 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.98899007 |
| 9 | MP0004270_analgesia | 2.91155766 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.89217850 |
| 11 | MP0003122_maternal_imprinting | 2.88755367 |
| 12 | MP0006276_abnormal_autonomic_nervous | 2.85781888 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.72698546 |
| 14 | MP0002272_abnormal_nervous_system | 2.72482707 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.64354454 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.54465176 |
| 17 | MP0002736_abnormal_nociception_after | 2.47119655 |
| 18 | MP0001486_abnormal_startle_reflex | 2.43959472 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.38650419 |
| 20 | MP0005645_abnormal_hypothalamus_physiol | 2.28521109 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.20393155 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.18812259 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.14434039 |
| 24 | MP0001970_abnormal_pain_threshold | 2.04892747 |
| 25 | MP0004142_abnormal_muscle_tone | 2.01583021 |
| 26 | MP0002822_catalepsy | 1.98489154 |
| 27 | MP0005386_behavior/neurological_phenoty | 1.83994437 |
| 28 | MP0004924_abnormal_behavior | 1.83994437 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.83014732 |
| 30 | MP0003329_amyloid_beta_deposits | 1.83009096 |
| 31 | MP0002184_abnormal_innervation | 1.80098041 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.78301169 |
| 33 | MP0001529_abnormal_vocalization | 1.77549399 |
| 34 | MP0008569_lethality_at_weaning | 1.71464648 |
| 35 | MP0001984_abnormal_olfaction | 1.67211868 |
| 36 | MP0001905_abnormal_dopamine_level | 1.65346192 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.65046804 |
| 38 | MP0003787_abnormal_imprinting | 1.56722873 |
| 39 | MP0000778_abnormal_nervous_system | 1.50266576 |
| 40 | MP0001502_abnormal_circadian_rhythm | 1.47238019 |
| 41 | MP0004858_abnormal_nervous_system | 1.44026620 |
| 42 | MP0000955_abnormal_spinal_cord | 1.43830145 |
| 43 | MP0004811_abnormal_neuron_physiology | 1.43320168 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.42019484 |
| 45 | MP0009780_abnormal_chondrocyte_physiolo | 1.37139255 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.35709438 |
| 47 | MP0004885_abnormal_endolymph | 1.33002403 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.27124062 |
| 49 | MP0000751_myopathy | 1.23786801 |
| 50 | MP0003121_genomic_imprinting | 1.23051550 |
| 51 | MP0003633_abnormal_nervous_system | 1.20954920 |
| 52 | MP0003123_paternal_imprinting | 1.20399139 |
| 53 | MP0001188_hyperpigmentation | 1.17790914 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.17689659 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.16389642 |
| 56 | MP0005551_abnormal_eye_electrophysiolog | 1.15822293 |
| 57 | MP0002229_neurodegeneration | 1.13345232 |
| 58 | MP0003879_abnormal_hair_cell | 1.11536877 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.09428525 |
| 60 | MP0003690_abnormal_glial_cell | 1.08445853 |
| 61 | MP0004742_abnormal_vestibular_system | 1.07823700 |
| 62 | MP0008872_abnormal_physiological_respon | 1.07239555 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.06016242 |
| 64 | MP0006072_abnormal_retinal_apoptosis | 1.04150713 |
| 65 | MP0003631_nervous_system_phenotype | 1.03365388 |
| 66 | MP0004147_increased_porphyrin_level | 1.00217960 |
| 67 | MP0002638_abnormal_pupillary_reflex | 0.98859786 |
| 68 | MP0002152_abnormal_brain_morphology | 0.97239531 |
| 69 | MP0003634_abnormal_glial_cell | 0.96874250 |
| 70 | MP0000920_abnormal_myelination | 0.94684581 |
| 71 | MP0005535_abnormal_body_temperature | 0.94317170 |
| 72 | MP0002069_abnormal_eating/drinking_beha | 0.93542661 |
| 73 | MP0001986_abnormal_taste_sensitivity | 0.92488656 |
| 74 | MP0003283_abnormal_digestive_organ | 0.86763717 |
| 75 | MP0000631_abnormal_neuroendocrine_gland | 0.84478352 |
| 76 | MP0001963_abnormal_hearing_physiology | 0.83628893 |
| 77 | MP0002752_abnormal_somatic_nervous | 0.82013302 |
| 78 | MP0000604_amyloidosis | 0.80463983 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.79744613 |
| 80 | MP0003632_abnormal_nervous_system | 0.78993271 |
| 81 | MP0008874_decreased_physiological_sensi | 0.78088611 |
| 82 | MP0001177_atelectasis | 0.76833982 |
| 83 | MP0004085_abnormal_heartbeat | 0.75601689 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.73126281 |
| 85 | MP0005499_abnormal_olfactory_system | 0.71218058 |
| 86 | MP0005394_taste/olfaction_phenotype | 0.71218058 |
| 87 | MP0002090_abnormal_vision | 0.71018052 |
| 88 | MP0004215_abnormal_myocardial_fiber | 0.70183333 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 0.69815370 |
| 90 | MP0005623_abnormal_meninges_morphology | 0.67631806 |
| 91 | MP0000747_muscle_weakness | 0.65009922 |
| 92 | MP0004043_abnormal_pH_regulation | 0.64399574 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.63725162 |
| 94 | MP0005253_abnormal_eye_physiology | 0.63276225 |
| 95 | MP0000569_abnormal_digit_pigmentation | 0.63228147 |
| 96 | MP0000026_abnormal_inner_ear | 0.62350422 |
| 97 | MP0001943_abnormal_respiration | 0.62242503 |
| 98 | MP0001664_abnormal_digestion | 0.62085773 |
| 99 | MP0000639_abnormal_adrenal_gland | 0.61554126 |
| 100 | MP0003861_abnormal_nervous_system | 0.60274850 |
| 101 | MP0001299_abnormal_eye_distance/ | 0.59504450 |
| 102 | MP0004233_abnormal_muscle_weight | 0.58639797 |
| 103 | MP0010769_abnormal_survival | 0.58152653 |
| 104 | MP0005187_abnormal_penis_morphology | 0.58146892 |
| 105 | MP0010770_preweaning_lethality | 0.57975734 |
| 106 | MP0002082_postnatal_lethality | 0.57975734 |
| 107 | MP0010768_mortality/aging | 0.55713390 |
| 108 | MP0002102_abnormal_ear_morphology | 0.53635698 |
| 109 | MP0001485_abnormal_pinna_reflex | 0.52776686 |
| 110 | MP0003956_abnormal_body_size | 0.51060932 |
| 111 | MP0003183_abnormal_peptide_metabolism | 0.50009255 |
| 112 | MP0004484_altered_response_of | 0.49579543 |
| 113 | MP0004130_abnormal_muscle_cell | 0.47660883 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.45815045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.39543057 |
| 2 | Myokymia (HP:0002411) | 5.81899006 |
| 3 | Focal seizures (HP:0007359) | 5.42741063 |
| 4 | Visual hallucinations (HP:0002367) | 5.30352177 |
| 5 | Atonic seizures (HP:0010819) | 5.24971843 |
| 6 | Absence seizures (HP:0002121) | 4.59757544 |
| 7 | Febrile seizures (HP:0002373) | 4.54215222 |
| 8 | Epileptic encephalopathy (HP:0200134) | 4.38767832 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.34638491 |
| 10 | Dialeptic seizures (HP:0011146) | 4.12685717 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.01471974 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.74483381 |
| 13 | Abnormal eating behavior (HP:0100738) | 3.66017907 |
| 14 | Polyphagia (HP:0002591) | 3.58685546 |
| 15 | Action tremor (HP:0002345) | 3.38255334 |
| 16 | Progressive inability to walk (HP:0002505) | 3.33353037 |
| 17 | Failure to thrive in infancy (HP:0001531) | 3.32415655 |
| 18 | Ankle clonus (HP:0011448) | 3.15838527 |
| 19 | Anxiety (HP:0000739) | 3.11040985 |
| 20 | Pheochromocytoma (HP:0002666) | 3.10109595 |
| 21 | Depression (HP:0000716) | 3.04538290 |
| 22 | Truncal ataxia (HP:0002078) | 3.03476264 |
| 23 | Dysdiadochokinesis (HP:0002075) | 3.01714052 |
| 24 | Limb dystonia (HP:0002451) | 2.96470538 |
| 25 | Dysmetria (HP:0001310) | 2.94562781 |
| 26 | Mutism (HP:0002300) | 2.92890540 |
| 27 | Broad-based gait (HP:0002136) | 2.89521561 |
| 28 | Akinesia (HP:0002304) | 2.86719766 |
| 29 | Postural instability (HP:0002172) | 2.77901047 |
| 30 | Neuroendocrine neoplasm (HP:0100634) | 2.75464491 |
| 31 | Amyotrophic lateral sclerosis (HP:0007354) | 2.74831240 |
| 32 | Gaze-evoked nystagmus (HP:0000640) | 2.74650406 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.72536098 |
| 34 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.71752860 |
| 35 | Agitation (HP:0000713) | 2.66254270 |
| 36 | Scanning speech (HP:0002168) | 2.64775681 |
| 37 | Hyperventilation (HP:0002883) | 2.64733829 |
| 38 | Cerebral hypomyelination (HP:0006808) | 2.62101357 |
| 39 | Papilledema (HP:0001085) | 2.61334264 |
| 40 | Abnormal hair whorl (HP:0010721) | 2.61080054 |
| 41 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.57428821 |
| 42 | Poor eye contact (HP:0000817) | 2.56239946 |
| 43 | Hemiparesis (HP:0001269) | 2.53546148 |
| 44 | Spastic gait (HP:0002064) | 2.47380480 |
| 45 | Impaired social interactions (HP:0000735) | 2.45695473 |
| 46 | Abnormal social behavior (HP:0012433) | 2.45695473 |
| 47 | Psychosis (HP:0000709) | 2.44471793 |
| 48 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.42686923 |
| 49 | Delusions (HP:0000746) | 2.40658264 |
| 50 | Diplopia (HP:0000651) | 2.40312399 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.40312399 |
| 52 | Excessive salivation (HP:0003781) | 2.38819092 |
| 53 | Drooling (HP:0002307) | 2.38819092 |
| 54 | Poor suck (HP:0002033) | 2.37712563 |
| 55 | Craniofacial dystonia (HP:0012179) | 2.37589228 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.37148466 |
| 57 | Urinary urgency (HP:0000012) | 2.36673785 |
| 58 | Hemiplegia (HP:0002301) | 2.36461948 |
| 59 | Status epilepticus (HP:0002133) | 2.35942811 |
| 60 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.35139172 |
| 61 | Bradykinesia (HP:0002067) | 2.34378306 |
| 62 | Abnormality of the corticospinal tract (HP:0002492) | 2.34180889 |
| 63 | Genetic anticipation (HP:0003743) | 2.32651170 |
| 64 | Amblyopia (HP:0000646) | 2.30915181 |
| 65 | Hypoventilation (HP:0002791) | 2.29545861 |
| 66 | Clonus (HP:0002169) | 2.29478115 |
| 67 | Gait imbalance (HP:0002141) | 2.28783712 |
| 68 | Esotropia (HP:0000565) | 2.28732737 |
| 69 | Intention tremor (HP:0002080) | 2.28564044 |
| 70 | Impaired vibratory sensation (HP:0002495) | 2.28016632 |
| 71 | Ventricular fibrillation (HP:0001663) | 2.27112085 |
| 72 | Generalized myoclonic seizures (HP:0002123) | 2.25974559 |
| 73 | Spastic tetraplegia (HP:0002510) | 2.21196167 |
| 74 | Oligomenorrhea (HP:0000876) | 2.20540359 |
| 75 | Retinal dysplasia (HP:0007973) | 2.18257143 |
| 76 | Narrow nasal bridge (HP:0000446) | 2.18120557 |
| 77 | Menstrual irregularities (HP:0000858) | 2.17943275 |
| 78 | Specific learning disability (HP:0001328) | 2.17940688 |
| 79 | Epileptiform EEG discharges (HP:0011182) | 2.17896234 |
| 80 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17488559 |
| 81 | Termporal pattern (HP:0011008) | 2.17432536 |
| 82 | Insidious onset (HP:0003587) | 2.17432536 |
| 83 | Abnormality of the lower motor neuron (HP:0002366) | 2.16892064 |
| 84 | Obstructive sleep apnea (HP:0002870) | 2.16169471 |
| 85 | Tetraplegia (HP:0002445) | 2.15639535 |
| 86 | Inability to walk (HP:0002540) | 2.11836656 |
| 87 | Impaired smooth pursuit (HP:0007772) | 2.10688805 |
| 88 | Peripheral hypomyelination (HP:0007182) | 2.10669444 |
| 89 | Apathy (HP:0000741) | 2.10613315 |
| 90 | Lower limb muscle weakness (HP:0007340) | 2.05675919 |
| 91 | Hypsarrhythmia (HP:0002521) | 2.04605785 |
| 92 | CNS hypomyelination (HP:0003429) | 2.03805227 |
| 93 | Absent speech (HP:0001344) | 2.02978474 |
| 94 | Fetal akinesia sequence (HP:0001989) | 2.01254986 |
| 95 | Annular pancreas (HP:0001734) | 2.00133047 |
| 96 | Sleep apnea (HP:0010535) | 1.98176202 |
| 97 | Neuronal loss in central nervous system (HP:0002529) | 1.97653140 |
| 98 | Congenital primary aphakia (HP:0007707) | 1.97060198 |
| 99 | Muscular hypotonia of the trunk (HP:0008936) | 1.95743917 |
| 100 | Abnormality of the labia minora (HP:0012880) | 1.95569193 |
| 101 | Blue irides (HP:0000635) | 1.95382706 |
| 102 | Torticollis (HP:0000473) | 1.94186747 |
| 103 | Abnormal ciliary motility (HP:0012262) | 1.93754434 |
| 104 | Incomplete penetrance (HP:0003829) | 1.92887508 |
| 105 | Hypoplasia of the corpus callosum (HP:0002079) | 1.92131809 |
| 106 | Rigidity (HP:0002063) | 1.90484437 |
| 107 | Gait ataxia (HP:0002066) | 1.89532257 |
| 108 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.88532998 |
| 109 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.87637938 |
| 110 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.87637938 |
| 111 | Heterochromia iridis (HP:0001100) | 1.86409376 |
| 112 | Diminished motivation (HP:0000745) | 1.86151378 |
| 113 | Focal dystonia (HP:0004373) | 1.85548387 |
| 114 | Postural tremor (HP:0002174) | 1.84517740 |
| 115 | Increased circulating renin level (HP:0000848) | 1.83920377 |
| 116 | Paraplegia (HP:0010550) | 1.83389393 |
| 117 | Type II lissencephaly (HP:0007260) | 1.83360284 |
| 118 | Choreoathetosis (HP:0001266) | 1.83352557 |
| 119 | Medial flaring of the eyebrow (HP:0010747) | 1.83064164 |
| 120 | Abnormality of saccadic eye movements (HP:0000570) | 1.81674678 |
| 121 | Megalencephaly (HP:0001355) | 1.81177989 |
| 122 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.80595347 |
| 123 | Hyperthyroidism (HP:0000836) | 1.79229486 |
| 124 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78773073 |
| 125 | Spastic tetraparesis (HP:0001285) | 1.77958951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.50305281 |
| 2 | MAP3K9 | 3.71967368 |
| 3 | MAP3K12 | 3.46790220 |
| 4 | MAP3K4 | 3.32341177 |
| 5 | MAP2K7 | 2.76628778 |
| 6 | MINK1 | 2.71263293 |
| 7 | MARK1 | 2.68784224 |
| 8 | NTRK2 | 2.48978930 |
| 9 | PNCK | 2.40612721 |
| 10 | MAP2K4 | 2.39576989 |
| 11 | EPHA4 | 2.35596702 |
| 12 | CASK | 2.28062656 |
| 13 | PAK6 | 2.01192216 |
| 14 | ARAF | 1.97761219 |
| 15 | NTRK1 | 1.95866097 |
| 16 | TNIK | 1.74964052 |
| 17 | KSR2 | 1.68782984 |
| 18 | CDK19 | 1.68481330 |
| 19 | UHMK1 | 1.56123521 |
| 20 | GRK5 | 1.54786681 |
| 21 | CDK5 | 1.41756994 |
| 22 | MAPK13 | 1.33892031 |
| 23 | FES | 1.33512621 |
| 24 | CAMKK1 | 1.32303445 |
| 25 | MAP3K13 | 1.31650331 |
| 26 | OXSR1 | 1.31177086 |
| 27 | TNK2 | 1.28156161 |
| 28 | DAPK2 | 1.27873551 |
| 29 | PHKG1 | 1.27823531 |
| 30 | PHKG2 | 1.27823531 |
| 31 | PLK2 | 1.25558595 |
| 32 | PRKCG | 1.24734512 |
| 33 | STK38 | 1.24172992 |
| 34 | CAMKK2 | 1.20532032 |
| 35 | CAMK2A | 1.13853676 |
| 36 | PRKD3 | 1.13677185 |
| 37 | RIPK4 | 1.13570747 |
| 38 | LMTK2 | 1.11812337 |
| 39 | MAP4K2 | 1.07554465 |
| 40 | LATS2 | 1.06645378 |
| 41 | PAK3 | 1.06095532 |
| 42 | KSR1 | 1.00862971 |
| 43 | STK39 | 0.98333499 |
| 44 | DYRK2 | 0.98095054 |
| 45 | SGK223 | 0.97461519 |
| 46 | SGK494 | 0.97461519 |
| 47 | GRK7 | 0.96649678 |
| 48 | SIK2 | 0.92749157 |
| 49 | TYRO3 | 0.90105581 |
| 50 | WNK3 | 0.88312860 |
| 51 | CDK14 | 0.88294578 |
| 52 | CAMK2B | 0.86807891 |
| 53 | WNK1 | 0.85499104 |
| 54 | CDK18 | 0.84604782 |
| 55 | PRPF4B | 0.84077448 |
| 56 | CDK15 | 0.83241888 |
| 57 | PRKCH | 0.82338392 |
| 58 | CSNK1G2 | 0.81018243 |
| 59 | MAP3K2 | 0.80509344 |
| 60 | CAMK2G | 0.78961313 |
| 61 | DAPK1 | 0.78653494 |
| 62 | CAMK1 | 0.77023336 |
| 63 | PINK1 | 0.76344324 |
| 64 | MAPK12 | 0.76295908 |
| 65 | MAPKAPK5 | 0.75765754 |
| 66 | STK11 | 0.75750107 |
| 67 | CAMK2D | 0.75553877 |
| 68 | CAMK4 | 0.73295794 |
| 69 | CAMK1G | 0.71932435 |
| 70 | CDK11A | 0.71441365 |
| 71 | SCYL2 | 0.67834724 |
| 72 | FER | 0.67656752 |
| 73 | MAP3K1 | 0.67430671 |
| 74 | ADRBK2 | 0.67373524 |
| 75 | PRKCE | 0.65578178 |
| 76 | WNK4 | 0.64874422 |
| 77 | SGK2 | 0.64371965 |
| 78 | RET | 0.63656016 |
| 79 | CSNK1A1L | 0.62216001 |
| 80 | TESK1 | 0.60473247 |
| 81 | TAOK2 | 0.60402328 |
| 82 | NME1 | 0.57494913 |
| 83 | DYRK1A | 0.56292824 |
| 84 | MUSK | 0.55926706 |
| 85 | SGK1 | 0.53809835 |
| 86 | ERBB3 | 0.52597993 |
| 87 | RAF1 | 0.51226270 |
| 88 | BCR | 0.49953444 |
| 89 | ADRBK1 | 0.49808974 |
| 90 | ROCK2 | 0.49206958 |
| 91 | RPS6KA3 | 0.48667906 |
| 92 | ALK | 0.48624603 |
| 93 | AKT3 | 0.48083491 |
| 94 | CSNK1G3 | 0.48004229 |
| 95 | CSNK1G1 | 0.47918367 |
| 96 | BRAF | 0.46960653 |
| 97 | MAPK10 | 0.46873273 |
| 98 | NEK6 | 0.46797129 |
| 99 | SGK3 | 0.46455641 |
| 100 | LIMK1 | 0.46434907 |
| 101 | CDC42BPA | 0.45262445 |
| 102 | IRAK2 | 0.43589090 |
| 103 | PRKCZ | 0.42253372 |
| 104 | PKN1 | 0.42050012 |
| 105 | PDPK1 | 0.41231412 |
| 106 | MARK2 | 0.40720435 |
| 107 | PRKACA | 0.39650112 |
| 108 | BMPR2 | 0.39244179 |
| 109 | FYN | 0.38848000 |
| 110 | PDK1 | 0.38107604 |
| 111 | PRKAA1 | 0.37681599 |
| 112 | PRKG1 | 0.37171252 |
| 113 | CSNK1D | 0.36952274 |
| 114 | MAP3K11 | 0.34921128 |
| 115 | PRKCA | 0.34142717 |
| 116 | MAP2K6 | 0.33861151 |
| 117 | DAPK3 | 0.33014403 |
| 118 | CSNK1A1 | 0.30262585 |
| 119 | CSNK1E | 0.29982516 |
| 120 | PRKCB | 0.28910045 |
| 121 | CCNB1 | 0.28700793 |
| 122 | CDK3 | 0.27894206 |
| 123 | FGFR2 | 0.27823599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.23417545 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.74810861 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 3.17404589 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.76089773 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.56593239 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.43591338 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.39678802 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.36006070 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.32628477 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26156796 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.20526492 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.19371869 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.08326510 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.03539739 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.95317873 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.95262954 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.92645372 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.90767620 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.78874940 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.78187639 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.78146044 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75168336 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.66711414 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.62832519 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.55792981 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.54916631 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.50067258 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44744806 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.39810420 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39714595 |
| 31 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.36751042 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35810092 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35324869 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.31421793 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.25579181 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23918500 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21705372 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.19513233 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06212170 |
| 40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05430777 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04264602 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02882615 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.00064150 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93986620 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.91710717 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91408838 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 0.90772111 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 0.90667942 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87877038 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86777298 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 0.84409077 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 0.81933785 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79512296 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78667574 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77438664 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75927109 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72534273 |
| 58 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72500574 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72155899 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.66327937 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.65422091 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64009043 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62240385 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61985299 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61385266 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60734175 |
| 67 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58526141 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57443027 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.54784593 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53719552 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53514093 |
| 72 | Alcoholism_Homo sapiens_hsa05034 | 0.53458289 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53039241 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52950004 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.50160762 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47884752 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47762034 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45478347 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44749049 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44029380 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42301804 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42257227 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42027986 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41508908 |
| 85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40452161 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35374756 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35143534 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33541578 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32523528 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.31066794 |
| 91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.31017416 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29960953 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.29941779 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29925113 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28740055 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28300486 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.26539014 |
| 98 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25281353 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25024027 |
| 100 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.23943632 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23844056 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23126691 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22436384 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.21235895 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21011056 |
| 106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.20079792 |
| 107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.17264064 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17216902 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.15693627 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.15631417 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.14372930 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.14164835 |

